Neurologix to showcase novel gene transfer approach to Parkinson’s disease

Download PDF Copy

Editorial Checklist

Reviewed

Sep 15 2009

NewsGuard 100/100 Score

Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that the company will showcase its novel gene transfer approach to Parkinson’s disease and other serious brain and central nervous system diseases at the BioPharm America partnering conference being held in San Francisco, CA on September 17 – 18. John Mordock, Neurologix President and Chief Executive Officer, will discuss the company’s technology, ongoing Phase 2 trial in advanced Parkinson’s disease and other development programs from 4:15 – 4:30 on Thursday September 17 in Salon 14 at the Marriott San Francisco.

Source:

http://www.neurologix.net/

Posted in: Medical Science News | Medical Condition News

Tags: Biotechnology, Brain, Central Nervous System, Chorea, Epilepsy, Gene, Gene Transfer, Nervous System, Parkinson's Disease, Technology

Comments (0)

Download PDF Copy

Suggested Reading

AI-powered tool predicts gene activity in cancer cells from biopsy images

AI-powered tool predicts gene activity in cancer cells from biopsy images

Pcdh8 gene suppression critical for zebrafish notochord formation

Pcdh8 gene suppression critical for zebrafish notochord formation

Innovative platform helps explore genetic links to 99 diseases

Innovative platform helps explore genetic links to 99 diseases

New study challenges the traditional view of gene switches

New study challenges the traditional view of gene switches

Groundbreaking method profiles gene activity in the living brain

Groundbreaking method profiles gene activity in the living brain

StitchR technology delivers large genes for muscular dystrophy treatment

StitchR technology delivers large genes for muscular dystrophy treatment

New study links circadian gene variants to winter depression

New study links circadian gene variants to winter depression

UAB researchers reverse liver disease in mice with gene therapy

UAB researchers reverse liver disease in mice with gene therapy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Researchers uncover key genes linked to DCIS progression